1. Anti-infection
  2. Parasite
  3. DM-1157

DM-1157 is an orally active asymmetric bisquinoline heme inhibitor with a IC50 of 1.6 μM and a Kd of 1.7 μM. DM-1157 binds to heme dimers in solution, inhibits β-hematin formation, suppresses hemozoin formation in the digestive vacuole of Plasmodium falciparum, accumulates in the digestive vacuole of Plasmodium falciparum, induces enlargement of the digestive vacuole of Plasmodium falciparum, and inhibits the growth of Chloroquine (HY-17589A)-sensitive and resistant Plasmodium falciparum strains. DM-1157 can be used for the research of malaria and Plasmodium falciparum-type malaria.

For research use only. We do not sell to patients.

DM-1157

DM-1157 Chemical Structure

CAS No. : 1239953-66-2

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

DM-1157 is an orally active asymmetric bisquinoline heme inhibitor with a IC50 of 1.6 μM and a Kd of 1.7 μM. DM-1157 binds to heme dimers in solution, inhibits β-hematin formation, suppresses hemozoin formation in the digestive vacuole of Plasmodium falciparum, accumulates in the digestive vacuole of Plasmodium falciparum, induces enlargement of the digestive vacuole of Plasmodium falciparum, and inhibits the growth of Chloroquine (HY-17589A)-sensitive and resistant Plasmodium falciparum strains. DM-1157 can be used for the research of malaria and Plasmodium falciparum-type malaria[1][2].

In Vitro

DM-1157 (Compound 22) (0.9-1.8 nM; 72 h) potently inhibits growth of chloroquine-sensitive D6, chloroquine-resistant Dd2, and chloroquine-resistant 7G8 Plasmodium falciparum strains in vitro with normalized IC50 values of 0.9 nM, 1.6 nM, and 1.8 nM, respectively[1].
DM-1157 (6500 nM) has a low in vitro cytotoxicity against murine spleenic lymphocytes, with a cytotoxicity IC50 of 6500 nM and a therapeutic index of 4060 relative to its antimalarial activity against Dd2 Plasmodium falciparum[1].
DM-1157 (10-50 nM; 24 h) potently inhibits hemozoin production in synchronized chloroquine-sensitive D6 and chloroquine-resistant Dd2 Plasmodium falciparum strains in vitro, with near-complete inhibition at 10 nM and complete inhibition at 50 nM, while inducing digestive vacuole enlargement[1].
DM-1157 (72 h) potently inhibits in vitro growth of chloroquine-sensitive P. falciparum D6 (IC50 = 0.2 nM) and chloroquine-resistant P. falciparum Dd2 (IC50 = 2.2 nM) and 7G8 (IC50 = 1.8 nM) strains, and shows cytotoxicity against mouse spleen lymphocytes with an LC50 of 6500 nM[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

DM-1157 (Compound 22) (30-46 mg/kg; p.o., s.c.; single dose, 4 consecutive daily doses; 24h post-infection, starting day 0 post-infection) exhibits potent oral and subcutaneous anti-malarial activity in P. berghei-infected NMRI mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NMRI (female)[1]
Dosage: 30 mg/kg (single oral dose); 30 mg/kg (single subcutaneous dose); 30 mg/kg (4 consecutive oral doses); 46 mg/kg (4 consecutive oral doses)
Administration: p.o. (single dose, 24h post-infection); s.c. (single dose, 24h post-infection); p.o. (4 consecutive daily doses, starting day 0 post-infection)
Result: Achieved 94% anti-malarial activity and a mean mouse survival time of 7 days.
Achieved 99.3% anti-malarial activity and a mean mouse survival time of 9 days.
Achieved > 99.9% anti-malarial activity, with 2 out of 3 mice cured (parasite-free at 30 days post-infection).
Achieved > 99.9% anti-malarial activity, with 9 out of 10 mice cured (parasite-free at 30 days post-infection), and the 10th mouse surviving to 29 days post-infection.
Molecular Weight

487.04

Formula

C28H31ClN6

CAS No.
SMILES

ClC1=CC2=NC=CC(NCCCN3CCC(CC3)NC(C4=NC=CC=C4)C5=NC=CC=C5)=C2C=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
DM-1157
Cat. No.:
HY-182394
Quantity:
MCE Japan Authorized Agent: